Home > Events >  “The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance” conference by M-CERSI

 “The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance” conference by M-CERSI

Looking forward to an exciting talk by our colleague Dorota Danielak at the upcoming “The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance” conference by M-CERSI!

📅 April 30 – May 1

📍 Universities at Shady Grove (Rockville, MD, USA), Building II

🗣️ Talk: Capturing Fasting Gastric Motility and pH Variability In Vitro to De-Risk Development of Oral Medicines

⏰ 1:10 PM – 1:30 PM


In this presentation, Dorota will dive into how complex fasting conditions – such as gastric motility, pH variability, temperature gradients, and non-linear gastric emptying – can be realistically reproduced in vitro to better understand drug dissolution.

👉 Registration available here: https://www.pharmacy.umaryland.edu/centers/cersievents/2025dissolution/


If you’re working in biopharmaceutics or drug development, this is definitely a session worth attending!